Understanding the Experiences and Challenges of People Living With Prostate Cancer
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Ankara University
- Enrollment
- 3,000
- Locations
- 1
- Primary Endpoint
- Characterization of global disparities in patient-reported experiences and quality of life among individuals with prostate cancer
Study Overview
Brief Summary
The PROSPEX (PROstate cancer Study of Patient EXperiences) survey is designed to systematically assess the lived experiences, challenges, and unmet needs of individuals diagnosed with prostate cancer. This observational study will collect patient-reported data on psychological, social, and practical aspects of living with prostate cancer, including the impact on quality of life and access to care. The findings aim to inform the development of patient-centered interventions and improve supportive care strategies in future clinical trials and routine practice.
Detailed Description
Prostate cancer is one of the most common cancers among men worldwide, and its impact extends far beyond medical treatment, affecting many aspects of patients' lives. The PROSPEX (PROstate cancer Study of Patient EXperiences) project is designed to systematically capture the real-world experiences, challenges, and needs of individuals living with prostate cancer across diverse healthcare settings and backgrounds.
Objectives
The primary objectives of the PROSPEX study are:
- To gather comprehensive, patient-reported data on the psychological, social, and practical challenges faced by people with prostate cancer, including the impact on quality of life, relationships, work, and daily living.
- To identify disparities in access to care, supportive services, and information, as well as differences in patient experiences based on disease stage, treatment history, and demographic factors.
- To inform the development of patient-centered care strategies and support services by highlighting unmet needs and areas for improvement in prostate cancer care.
Methods
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults (aged 18 years or older). Diagnosed with prostate cancer at any stage (localized, locally advanced, metastatic, or recurrent).
- •Able to understand and provide informed consent for participation. Willing and able to complete the online survey in the available languages. Access to the internet and a device to complete the survey.
Exclusion Criteria
- •Individuals who have not been diagnosed with prostate cancer. Individuals under 18 years of age. Inability to provide informed consent. Inability to complete the survey due to cognitive, language, or technical barriers.
Outcomes
Primary Outcomes
Characterization of global disparities in patient-reported experiences and quality of life among individuals with prostate cancer
Time Frame: One month
Comparative analyses will be performed using survey data to identify and quantify differences in patient experiences, quality of life, and unmet needs across various regions and healthcare settings. Results will be reported as percentages of respondents, with thorough evaluation of territorial, institutional, and socioeconomic differences. Participants will be categorized according to the World Bank's income classification: low- and lower-middle-income countries, upper-middle-income countries, and high-income countries. Descriptive statistics will be used to compare demographic and clinical characteristics, as well as patient-reported outcomes. For categorical data, Pearson Chi-Square or Fisher's Exact test will be applied; for continuous variables, ANOVA will be used. A p-value of less than 0.05 will be considered statistically significant.
Secondary Outcomes
- Identification of factors associated with reduced quality of life and increased psychosocial burden in prostate cancer patients(one month)
- Assessment of disparities in access to supportive care and information among prostate cancer patients(one month)
Investigators
Yüksel Ürün
Professor doctor
Ankara University